They have discovered that the IL-1 receptor antagonist (IL-1ra) not only decreases IL-1β-induced long-lasting cognitive impairments but also suppresses microglia activation and IL-1β production (Terrando et al., 2010; Wang et al., 2013; Lan et al., 2015). Here, IL1B is linked to Cognitive impairment.